A. Thompson

发表

Brain lesion location and clinical status 20 years after a diagnosis of clinically isolated syndrome suggestive of multiple sclerosis

AJ Thompson, O Ciccarelli, M. Battaglini, 2012, Multiple sclerosis.

Neurite orientation dispersion and density imaging (NODDI) reflects early microstructural brain tissue changes in clinically isolated syndrome (CIS)

S. Ourselin, O. Ciccarelli, A. Toosy, 2016 .

Development of novel clinical examination scales for the measurement of disease severity in Creutzfeldt-Jakob disease

S. Mead, J. Collinge, P. Rudge, 2020, Journal of Neurology, Neurosurgery, and Psychiatry.

Neutralising antibodies to interferon β during the treatment of multiple sclerosis

L. Kappos, C. Polman, J. Petkau, 2003, Journal of neurology, neurosurgery, and psychiatry.

A longitudinal study of the cortical response to photic stimulation after acute optic neuritis by using functional magnetic resonance imaging: A preliminary analysis

G. Plant, G. Barker, A. Toosy, 2002 .

A serial MRI study of spinal cord atrophy in multiple sclerosis using an active surface segmentation technique.

S. Arridge, G. Barker, G. Parker, 2002 .

Extensive brain activation following recovery from optic neuritis : a pilot study using functional magnetic resonance imaging (fMRI)

G. Barker, M. Brammer, D. Miller, 1999 .

Generating synthetic DIR images using multi-parameter maps; application to lesion detection in MS.

Nikolaus Weiskopf, Antoine Lutti, David L. Thomas, 2012 .

Deep-brain stimulation in Parkinson's disease

M. Sailer, A. Coles, P. Brex, 2006 .

Adaptive cortical reorganization in acute optic neuritis: Longitudinal functional magnetic resonance imaging study

Gareth J. Barker, Dh Miller, Aj Thompson, 2004 .

The pathogenesis of lesions and normal appearing white matter changes in multiple sclerosis: A serial diffusion magnetic resonance imaging study

Symms, Gareth J. Barker, Dh Miller, 2000 .

Diffusion tensor imaging detects corticospinal tract involvement at multiple levels in ALS.

Gareth J. Barker, Dh Miller, Aj Thompson, 2003 .

Quadrant specific visual functional MRI in acute optic neuritis

Laura Mancini, Dh Miller, Aj Thompson, 2007 .

Phenylketonuria due to phenylalanine hydroxylase deficiency: an unfolding story. Medical Research Council Working Party on Phenylketonuria.

R. Surtees, S. Malcolm, L. Tyfield, 1993, BMJ.

Lesion heterogeneity in MS: a study of the relationships between appearances on T1-weighted images, T1 relaxation times and metabilite concentrations

G. Barker, G. Parker, D. Miller, 2000 .

Diffusion Tensor Imaging of Basal Ganglia in Multiple Sclerosis

G. Barker, O. Ciccarelli, D. Werring, 2001 .

Shortening inpatient stay for stroke

N. Losseff, E. Playford, A. Thompson, 2002, The Lancet.

MRI measures show significant cerebellar gray matter volume loss in multiple sclerosis and are associated with cerebellar dysfunction

D. Altmann, D. Miller, L. Fisniku, 2009, Multiple sclerosis.

Serial Gd-DTPA MRI reveals differences between primary and secondary progressive multiple sclerosis

A. Kermode, W. Mcdonald, B. Kendall, 1989 .

Sudden Unexpected Death in Infancy: place and time of death

A. Thompson, J. Glasgow, P. Ingram, 2006, The Ulster medical journal.

A comprehensive assessment of cerebellar damage in multiple sclerosis using diffusion tractography and volumetric analysis

AJ Thompson, O Ciccarelli, O. Ciccarelli, 2011, Multiple sclerosis.

Early pericalcarine atrophy in acute optic neuritis is associated with conversion to MS

O. Ciccarelli, A. Toosy, D. Miller, 2011 .

Multisequence MRI in clinically isolated syndromes and the early development of MS

I. Moseley, K. Miszkiel, J. O'riordan, 1999, Neurology.

Brain atrophy and lesion load measures over 1 year relate to clinical status after 6 years in patients with clinically isolated syndromes

M. Filippo, D. Altmann, V. Anderson, 2009, Journal of Neurology, Neurosurgery & Psychiatry.

Interferon beta in multiple sclerosis: experience in a British specialist multiple sclerosis centre

P. Rudge, G. Giovannoni, R. Kapoor, 2003, Journal of neurology, neurosurgery, and psychiatry.

Interferon beta-1b treatment does not induce autoantibodies

C. Pozzilli, L. Kappos, C. Polman, 2005, Neurology.

Hippocampal atrophy in relapsing-remitting and primary progressive MS: a comparative study

Z Khaleeli, A J Thompson, A. Thompson, 2010, Multiple sclerosis.

Relationship of triple dose contrast enhanced lesions with clinical measures and brain atrophy in early relapsing-remitting multiple sclerosis: a two-year longitudinal study

D. Miller, W. Rashid, D. Chard, 2007, Multiple sclerosis.

Outcome measures for multiple sclerosis clinical trials: relative measurement precision of the Expanded Disability Status Scale and Multiple Sclerosis Functional C omposite

F. Barkhof, C. Polman, J. Hobart, 2004, Multiple sclerosis.

Grey matter damage and overall cognitive impairment in primary progressive multiple sclerosis

O. Ciccarelli, A. Thompson, M. Ron, 2011, Multiple sclerosis.

Normal-appearing grey and white matter T1 abnormality in early relapsing–remitting multiple sclerosis: a longitudinal study

A J Thompson, G J Parker, A Hadjiprocopis, 2007, Multiple sclerosis.

The search for responsive clinical endpoints in primary progressive multiple sclerosis

X. Montalban, C. Polman, M. Tintoré, 2009, Multiple sclerosis.

Primary progressive multiple sclerosis diagnostic criteria: a reappraisal

A. Thompson, F. Barkhof, M. Rovaris, 2009, Multiple sclerosis.

CURRENT MANAGEMENT OF MULTIPLE SCLEROSIS

A. Thompson, S. Leary, A. Thompson, 2000, International journal of clinical practice.

Neutralizing anti-interferon beta antibodies are associated with reduced side effects and delayed impact on efficacy of Interferon-beta

D. Miller, P. Rudge, G. Giovannoni, 2008, Multiple sclerosis.

Early MRI in optic neuritis: the risk for clinically definite multiple sclerosis

D. Altmann, K. Miszkiel, J. Swanton, 2010, Multiple sclerosis.

Progression on the Multiple Sclerosis Functional Composite in multiple sclerosis: what is the optimal cut-off for the three components?

AJ Thompson, Z. Khaleeli, X. Montalban, 2010, Multiple sclerosis.

A phase II trial of anti-CD4 antibodies in the treatment of multiple sclerosis

F. Barkhof, C. Polman, D. Miller, 1996, Multiple sclerosis.

Optic nerve magnetization transfer imaging and measures of axonal loss and demyelination in optic neuritis

D. Miller, D. Garway-Heath, A. Thompson, 2007, Multiple sclerosis.

LETTERS TO THE EDITOR

A. Kermode, W. Mcdonald, P. Rudge, 1990 .

Magnetization transfer ratio abnormalities reflect clinically relevant grey matter damage in multiple sclerosis

A. Thompson, M. Cercignani, K. Schmierer, 2009, Multiple sclerosis.

Triple dose gadolinium enhanced MRI of the brain and spinal cord in early relapsing remitting multiple sclerosis is predictive of future relapses

D. Miller, D. Chard, W. Rashid, 2002 .

Disability and T2 MRI abnormalities: A 20 year follow-up of patients with relapse onset of multiple sclerosis

Altmann, D. Miller, K. Miszkiel, 2007 .

Spinal cord atrophy and disability in multiple sclerosis: a longitudinal study

Dh Miller, Aj Thompson, Gjm Parker, 1998 .

Socio-demographic predictors of health-related quality of life in multiple sclerosis and comparisons with other populations

J. Hobart, D. Lamping, R. Fitzpatrick, 2001 .

H-1 magnetic resonance spectroscopy of normal-appearing white matter in primary progressive multiple sclerosis

D. MacManus, G. Parker, D. Miller, 1998 .

Interferon-beta-1b reduces development of T1 black holes on MRI in secondary progressive multiple sclerosis

Ludwig Kappos, Tarek A. Yousry, Massimo Filippi, 2000 .

MRI monitoring of cerebral atrophy during a placebo-controlled trial of interferon-beta-1b in secondary progressive multiple sclerosis

F. Barkhof, M. Filippi, C. Pozzilli, 2000 .

Urinary neopterin and nitric oxide metabolites as markers of interferon β-1a activity in primary progressive multiple sclerosis

D. Miller, D. Miller, G. Giovannoni, 2010, Multiple sclerosis.

Quantitative MRI in patients with clinically isolated syndromes suggestive of demyelination

D. Miller, W. Mcdonald, M. Sailer, 1999, Neurology.

The predictive value of brain lesion load in determining brain atrophy in multiple sclerosis: 14 year follow up data following first presentation with a clinically isolated syndrome

Dh Miller, Aj Thompson, Declan T. Chard, 2002 .

Are magnetic resonance findings predictive of clinical outcome in therapeutic trials in multiple sclerosis? The dilemma of interferon‐β

D. Miller, W. Mcdonald, A. J. Thompson, 1994, Annals of neurology.

Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: Results of a randomized, double-blind, placebo-controlled MR-monitored phase II trial

F. Barkhof, C. Polman, D. Miller, 1997, Neurology.

Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression.

A. Thompson, G. Barker, D. Miller, 1996, Brain : a journal of neurology.

Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes

A. Thompson, G. Plant, K. Miszkiel, 2005, Journal of Neurology, Neurosurgery & Psychiatry.

The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up.

A. Thompson, D. Miller, D. MacManus, 1998, Brain : a journal of neurology.

One year follow up study of primary and transitional progressive multiple sclerosis

A. Thompson, F. Barkhof, M. Rovaris, 2000, Journal of neurology, neurosurgery, and psychiatry.

Cognitive function in primary progressive and transitional progressive multiple sclerosis: a controlled study with MRI correlates.

A. Thompson, M. Filippi, D. Miller, 1999, Brain : a journal of neurology.

Major differences in the dynamics of primary and secondary progressive multiple sclerosis

A. Thompson, D. MacManus, A. Kermode, 1991, Annals of neurology.

Spinal cord MRI using multi‐array coils and fast spin echo

A. Thompson, D. Miller, D. MacManus, 1993, Neurology.

Neutralizing antibodies during treatment of secondary progressive MS with interferon β-1b

C. Pozzilli, L. Kappos, C. Polman, 2003, Neurology.

The X-Linked Intellectual Disability gene, ZDHHC9, is important for oligodendrocyte maturation and myelin formation

S. Flibotte, A. Thompson, SX Bamji, 2023, bioRxiv.

Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing-remitting multiple sclerosis

W. I. McDonald, B. E. Kendall, J. W. Thorpe, 1996, Neurology.

Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis.

A. Thompson, G. Plant, D. MacManus, 2004, Brain : a journal of neurology.

Executive function in multiple sclerosis. The role of frontal lobe pathology.

J Foong, A J Thompson, L Rozewicz, 1997, Brain : a journal of neurology.

Daily urinary neopterin excretion as an immunological marker of disease activity in multiple sclerosis.

D. Miller, D. Kidd, G. Giovannoni, 1997, Brain : a journal of neurology.

Evaluating neurorehabilitation: lessons from routine data collection

A. Thompson, J. Hobart, E. Playford, 2005, Journal of Neurology, Neurosurgery & Psychiatry.

Longitudinal study of soluble adhesion molecules in multiple sclerosis

A. Thompson, D. Miller, D. Miller, 1997, Neurology.

Correlation of magnetization transfer ration with clinical disability in multiple sclerosis

G. Barker, A. Thompson, D. MacManus, 1994, Annals of neurology.

Use of magnetic-resonance spectroscopy to investigate disability in multiple-sclerosis

G. Barker, D. Miller, C. Davie, 1994 .